Hard2beat

Insights & Resources

Practical resources to help you build smarter and move faster.

Inside Hard2beat

Our latest deals, how we work, and our take on where the market’s headed.

Hard2beat

Why we invested in Melanos Care

Melanos Care is a biotech startup redefining skincare with their natural bio-identical melanin from stem cells. It’s a long-lasting solution that blocks sun radiation, the main cause of skin cancer, burns and 80% of visible aging signs, overcoming the limitations of traditional UV creams.

Read More »
Michał Lechowski

Deep Tech January 2026: Dry January? Not for the Engineers.

While the world was busy with New Year’s resolutions and holiday leftovers, European R&D labs were hard at work. In January, investors backed 74 companies tackling “absurdly hard” challenges – from treating brain tumors with electricity to wirelessly powering artificial hearts and manufacturing quantum computers in smartphone factories.

Read More »
Maciej Frankowicz

Why we invested in Ludus AI

Ludus AI is developing a next-generation solution for the 3D game and visualization industry. The company focuses on simplifying the creation of high-quality content in Unreal Engine through the use of artificial intelligence.

Read More »
Konrad Trzyna

Why we invested in Pikralida

Pikralida is developing PKL-021, a rediscovered small-molecule MMP inhibitor that has completed Phase I and is now being advanced into Phase II-ready programs to provide acute neuroprotection after stroke and traumatic brain injury and to offer fast, field-ready treatment for venomous snakebites in humans and pets.

Read More »
Konrad Trzyna

Why we invested in Neuromedical

Neuromedical has developed VGuard, a non-invasive method that has demonstrated significant improvements in cognitive function in Alzheimer’s patients in clinical trials.

Read More »
Maciej Zawadziński

Why we invested in Defguard

Defguard brings the benefits of modern and flexible VPN & access management with advanced security features and control that enterprises need.

Read More »

Podcasts & Videos

Real stories and lessons from Hard2beat, our founders, and friends in the ecosystem.

Hard2beat Podcast #1 – Odpalamy fundusz

Pierwszy odcinek podcastu Hard2beat już jest! Jesteśmy nowym funduszem VC z ambicją wspierania founderów od samego startu Żeby przybliżyć Wam naszą wizję zamierzamy co jakiś czas tworzyć treści audio i wideo

Read More »

Media & Press

News, deal announcements and expert takes from the Hard2beat team as seen in top publications.

Jedyna na świecie naturalna melanina powstanie w Polsce? Krakowski startup Melanos Care pozyskuje środki na dalszy rozwój

Spółka Melanos Care ogłosiła zamknięcie rundy inwestycyjnej o łącznej wartości 5,4 mln zł. Finansowanie zapewnił fundusz Hard2beat oraz liczna grupa aniołów biznesu. Pozyskany kapitał zostanie przeznaczony na skalowanie procesu produkcji bioidentycznej melaniny do poziomu pilotażowego oraz dalsze prace badawczo-rozwojowe i certyfikację.

Read More »

Ludus AI raises $1.3M for generative AI copilot for Unreal Engine devs

Ludus AI has raised $1.3 million to support its generative AI copilot for Unreal Engine developers. The round includes funding from technology investors, including Hartmann Capital, Artificial Agency, Hard2Beat, and 24Ventures. The funding will support continued development of Ludus AI’s proprietary technology and help lower the technical barriers Unreal Engine

Read More »

VC of the month — Hard2beat

Hard2beat is a new €20 million early-stage VC fund founded by entrepreneurs and technology investors based in Poland. It focuses on deeptech companies with a strong technological edge — teams solving complex technical problems across multiple fields.

Read More »

Fundusz Hard2beat zainwestował w trzy spółki

Nowy fundusz venture capital, Hard2beat, który został zasilony pieniędzmi od PFR Ventures, zaczął inwestować. Z rozmachem, ponieważ przeznaczył 7,5 mln zł na trzy start-upy. W planach ma zainwestowanie w kolejnych pięć do końca tego roku.

Read More »

Founder Resources

Explore best perks for our portfolio companies.